Literature DB >> 17339240

Therapeutic potential of fractalkine: a novel approach to metastatic colon cancer.

M Brueckmann1, M Borggrefe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17339240      PMCID： PMC1856811          DOI： 10.1136/gut.2006.103317

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  17 in total

1.  Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer.

Authors:  S Vitale; B Cambien; B F Karimdjee; R Barthel; P Staccini; C Luci; V Breittmayer; F Anjuère; A Schmid-Alliana; H Schmid-Antomarchi
Journal:  Gut       Date:  2006-07-26       Impact factor: 23.059

2.  A new class of membrane-bound chemokine with a CX3C motif.

Authors:  J F Bazan; K B Bacon; G Hardiman; W Wang; K Soo; D Rossi; D R Greaves; A Zlotnik; T J Schall
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

3.  Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.

Authors:  S Faure; L Meyer; D Costagliola; C Vaneensberghe; E Genin; B Autran; J F Delfraissy; D H McDermott; P M Murphy; P Debré; I Théodorou; C Combadière
Journal:  Science       Date:  2000-03-24       Impact factor: 47.728

4.  Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.

Authors:  J H Ruth; M V Volin; G K Haines; D C Woodruff; K J Katschke; J M Woods; C C Park; J C Morel; A E Koch
Journal:  Arthritis Rheum       Date:  2001-07

5.  Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).

Authors:  K J Garton; P J Gough; C P Blobel; G Murphy; D R Greaves; P J Dempsey; E W Raines
Journal:  J Biol Chem       Date:  2001-08-08       Impact factor: 5.157

6.  Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients.

Authors:  A Foussat; L Bouchet-Delbos; D Berrebi; I Durand-Gasselin; A Coulomb-L'Hermine; R Krzysiek; P Galanaud; Y Levy; D Emilie
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

7.  A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection.

Authors:  L A Robinson; C Nataraj; D W Thomas; D N Howell; R Griffiths; V Bautch; D D Patel; L Feng; T M Coffman
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

8.  Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.

Authors:  T Imai; K Hieshima; C Haskell; M Baba; M Nagira; M Nishimura; M Kakizaki; S Takagi; H Nomiyama; T J Schall; O Yoshie
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

9.  Fractalkine-mediated endothelial cell injury by NK cells.

Authors:  O Yoneda; T Imai; S Goda; H Inoue; A Yamauchi; T Okazaki; H Imai; O Yoshie; E T Bloom; N Domae; H Umehara
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

10.  Chemoattraction, adhesion and activation of natural killer cells are involved in the antitumor immune response induced by fractalkine/CX3CL1.

Authors:  Jun Guo; Taoyong Chen; Baocheng Wang; Minghui Zhang; Huazhang An; Zhenhong Guo; Yizhi Yu; Zhihai Qin; Xuetao Cao
Journal:  Immunol Lett       Date:  2003-10-09       Impact factor: 3.685
View more
  4 in total

Review 1.  Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment.

Authors:  Alain E Andrea; Andrada Chiron; Sarah Mallah; Stéphanie Bessoles; Guillaume Sarrabayrouse; Salima Hacein-Bey-Abina
Journal:  Front Immunol       Date:  2022-02-08       Impact factor: 7.561

Review 2.  Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner.

Authors:  Thomas Dittmar; Christoph Heyder; Eva Gloria-Maercker; Wolfgang Hatzmann; Kurt S Zänker
Journal:  Clin Exp Metastasis       Date:  2007-09-08       Impact factor: 5.150

3.  Vertebral-specific activation of the CX3CL1/ICAM-1 signaling network mediates non-small-cell lung cancer spinal metastasis by engaging tumor cell-vertebral bone marrow endothelial cell interactions.

Authors:  Ketao Wang; Libo Jiang; Annan Hu; Chi Sun; Lei Zhou; Yiwei Huang; Qing Chen; Jian Dong; Xiaogang Zhou; Feng Zhang
Journal:  Theranostics       Date:  2021-03-04       Impact factor: 11.556

4.  Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient.

Authors:  Imran Siddiqui; Marco Erreni; Mandy van Brakel; Reno Debets; Paola Allavena
Journal:  J Immunother Cancer       Date:  2016-04-19       Impact factor: 13.751
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.